vorinostat has been researched along with Heart Failure in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagata, S | 1 |
| Marunouchi, T | 1 |
| Tanonaka, K | 1 |
| Wang, D | 1 |
| Fang, C | 1 |
| Zong, NC | 1 |
| Liem, DA | 1 |
| Cadeiras, M | 1 |
| Scruggs, SB | 1 |
| Yu, H | 1 |
| Kim, AK | 1 |
| Yang, P | 1 |
| Deng, M | 1 |
| Lu, H | 1 |
| Ping, P | 1 |
2 other studies available for vorinostat and Heart Failure
| Article | Year |
|---|---|
Histone Deacetylase Inhibitor SAHA Treatment Prevents the Development of Heart Failure after Myocardial Infarction via an Induction of Heat-Shock Proteins in Rats.
Topics: Animals; Gene Expression Regulation; Heart Failure; Heat-Shock Proteins; Histone Deacetylase Inhibit | 2019 |
Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human.
Topics: Acetylation; Animals; Chromatography, Liquid; Gene Expression Regulation; Heart Failure; Heart Trans | 2013 |